Ocular Research of Boston is categorized under Business Services (Unclassified) in Boston, MA and active since 2010.
Ocular Research of Boston was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact Donald Korb, Owner at the company’s single location by writing to 400 Commonwealth Avenue # 2, Boston, Massachusetts MA 02215 or by phoning (617) 423-6370. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Ocular Research of Boston |
Contact Person: | Donald Korb, Owner |
Address: | 400 Commonwealth Avenue # 2, Boston, Massachusetts 02215 |
Phone Number: | (617) 423-6370 |
Annual Revenue (USD): | Unknown |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Business Services (Unclassified) |
SIC Code: | 7389 |
NAICS Code: | 561499 |
Share This Business: |
Ocular Research of Boston was started in 2010 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Donald Korb, Owner for inquiries that concern Ocular Research of Boston by calling the company number (617) 423-6370, as your correspondence is most welcome. Additionally, the physical location of the single location of Ocular Research of Boston can be found at the coordinates 42.348847,-71.090162 as well as the street address 400 Commonwealth Avenue # 2 in Boston, Massachusetts 02215.
For its online presence, you may visit Ocular Research of Boston’s website at and engage with its social media outlets through on Twitter and on Facebook.